Saturday, July 11, 2026

pharma · Colorectal Cancer Metastatic

Dai, Guanghai

Dai, Guanghai trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Trials

Dai, Guanghai clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Dai, Guanghai programs — each row shows trial ID, program name, phase, status, and indication.

Dai, Guanghai trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Dai, Guanghai.

  1. Fruquintinib — Phase 2

    Clinical update

Trial registry

1 studies